The first-ever daily pill for prevention against HIV was approved Monday by United States regulators for use in uninfected adults who are at riskof contacting the virus that causes AIDS.
The name of the drug is ‘Truvada’, made by Gilead Sciences in California, and it has been available since 2004. But it has just just been approved by the Food and Drug Administration (FDA) for a new use as a tool to help ward off HIV in healthy people.
The pill as pre-exposure prophylaxis (PrEP) has been hailed by some AIDS experts as a potent new tool against human immunodeficiency virus.
The FDA however encouraged adults use Truvada as “part of a comprehensive HIV prevention strategy that includes other prevention methods, such as safesex practices, risk reduction counseling, and regular HIV testing.”
